Related references
Note: Only part of the references are listed.Intradermal vaccine delivery: Will new delivery systems transform vaccine administration?
Paul Henri Lambert et al.
VACCINE (2008)
Sexual dimorphism of humoral immunity with human vaccines
Ian Francis Cook
VACCINE (2008)
Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults
IF Cook et al.
VACCINE (2006)
Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal®) in the elderly
V D'Acremont et al.
JOURNAL OF TRAVEL MEDICINE (2006)
Interchangeability and tolerability of a virosomal and an aluminum-adsorbed hepatitis A vaccine
PA Bovier et al.
VACCINE (2005)
Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal®) in healthy toddlers and children in Chile
S Riedemann et al.
ACTA PAEDIATRICA (2004)
Dose sparing with intradermal injection of influenza vaccine
RT Kenney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal®)
V Usonis et al.
VACCINE (2003)
Efficacy of virosome hepatitis A vaccine in young children in nicaragua:: Randomized placebo-controlled trial
OM Pérez et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA®) in adults:: safety, tolerability, and immunogenicity
T Linglöf et al.
VACCINE (2001)
Share Paper
